Top

Published in:

Open Access 01-12-2020 | Influenza Vaccination | Research

Influenza coverage rates in subjects with chronic heart diseases: results obtained in four consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy)”

Authors: Armando Stefanati, Silvia Lupi, Gianluca Campo, Silvia Cocchio, Patrizia Furlan, Vincenzo Baldo, Giovanni Gabutti

Published in: Archives of Public Health | Issue 1/2020

Abstract

Background

Seasonal influenza epidemics yearly affects 5–15% of the world’s population, resulting in 3–5 million serious cases and up to 650,000 deaths. According to the 2017–2019 Italian National Immunisation Plan, free immunisation is offered to the categories at increased risk of experience the complications of the infection (over 65 years old subjects, pregnant women and individuals with underlying conditions, including chronic heart diseases). Rising evidence suggests that influenza can trigger adverse cardiovascular events therefore the vaccination is recommended for secondary prevention of cardiovascular diseases. Despite this, the influenza coverage rate in subjects with chronic heart disease is underestimated.

Methods

The study investigated the coverage rate in four consecutive influenza seasons (from 2011/2012 to 2014/2015) in subjects that benefit from exemption from paying healthcare costs for chronic heart disease living in Local Health Unit (LHU) of Ferrara (Italy), comparing the databases of exemptions and immunisations.

Results

The levels of influenza vaccine uptake were unstable, reaching the 50.3% in 2011/2012 immunisation season and falling to 42.2% in the following year. Coverage rates increased with increasing age, without achieving the 75% target, neither in over 65 years old subjects. The logistic regression analysis showed that influenza coverage rates were statistically significant different (p < 0.0001, 0.003 only for category of disease in 2011/2012 immunisation season) according to age, district of residence, category of chronic heart disease and length of exemption, but not influenced by gender.

Conclusions

The recommendation of influenza immunisation was weakly followed in individuals with chronic heart diseases. A collaboration between cardiologists, GPs, scientific societies and patient associations could successfully support influenza vaccine uptake.

Available only for authorised users

World Health Organization (WHO). Influenza (2019). www.who.int/influenza/surveillance_monitoring/bod/en. Accessed 3 September 2019.

Bella A, Castrucci MR. La sorveglianza integrata dell’influenza in Italia: i risultati della stagione 2018–19. Bollettino Epidemiologico Nazionale 2019; luglio-agosto. https://www.epicentro.iss.it/ben/2019/luglio-agosto/sorveglianza-integrata-influenza-2018-19?utm_source=newsletter&utm_medium=email&utm_campaign=26settembre2019. Accessed 3 September 2019.

Mertz D, Kim TH, Johnstone J, Lam P-P, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, Loeb M. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061. https://doi.org/10.1136/bmj.f5061.CrossRefPubMedPubMedCentral

Gasparini R, Amicizia D, Lai PL, Panatto D. Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly. Hum Vaccines Immunother. 2012;8(1):21–8. https://doi.org/10.4161/hv.8.1.17622.CrossRef

Lu PJ, O’Halloran A, Ding H, Srivastav A, Williams WW. Uptake of influenza vaccination and missed opportunities among adults with high-risk conditions, United States, 2013. Am J Med. 2016;129(6):636.e1–636.e11. https://doi.org/10.1016/j.amjmed.2015.10.031.CrossRef

Mackenbach JP, Kunst AE, Looman CW. Seasonal variation in mortality in the Netherlands. J Epidemiol Community Health. 1992;46(3):261–5.CrossRefPubMedPubMedCentral

Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol. 2004;160(5):492–502.CrossRefPubMed

Fleming DM, Cross KW, Pannell RS. Influenza and its relationship to circulatory disorders. Epidemiol Infect. 2005;133(2):255–62.CrossRefPubMedPubMedCentral

Gurevich VS, Pleskov VM, Levaia MV, Bannikov AI, Mitrofanova LB, Urazgil’deeva SA. Influenza virus infection in progressing atherosclerosis. Kardiologia. 2002;42(7):21–4.

10.

MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102(24):1953–6. https://doi.org/10.1136/heartjnl-2016-309983.CrossRefPubMed

11.

Spencer FA, Goldberg RJ, Becker RC, Gore JM. Seasonal distribution of acute myocardial infarction in the second National Registry of myocardial infarction. J Am Coll Cardiol. 1998;31(6):1226–33.CrossRefPubMed

12.

Clayton TC, Capps NE, Stephens NG, Wedzicha JA, Meade TW. Recent respiratory infection and the risk of myocardial infarction. Heart. 2005;91(12):1601–2.CrossRefPubMedPubMedCentral

13.

Casscells SW, Granger E, Kress AM, Linton A, Madjid M, Cottrell L. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes. 2009;2(2):108–15. https://doi.org/10.1161/CIRCOUTCOMES.108.820357.CrossRefPubMed

14.

Ciszewski A. Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases. Vaccine. 2018;36(2):202–6. https://doi.org/10.1016/j.vaccine.2017.11.078.CrossRefPubMed

15.

Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and cardiovascular outcomes in high-risk patients. A meta-analysis. JAMA. 2013;310(16):1711–20. https://doi.org/10.1001/jama.2013.279206.CrossRefPubMed

16.

Mohseni H, Kiran A, Khorshidi R, Rahimi K. Influenza vaccination and risk for hospitalization in patients with heart failure: a self-controlled case series study. Eur Heart J. 2017;38(5):326–33. https://doi.org/10.1093/eurheartj/ehw411.CrossRefPubMed

17.

Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation. 2003;108(22):2730–6.CrossRefPubMed

18.

Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A. Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism. Vaccine. 2014;32(48):6569–75. https://doi.org/10.1016/j.vaccine.2014.07.007.CrossRefPubMed

19.

Burney LE. Influenza immunization: Statement. Public Health Rep. 1960;75(10):944.CrossRefPubMedPubMedCentral

20.

Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Bresee JS, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices — United States, 2017–18 influenza season. MMWR Recomm Rep. 2017;66(2):1–20. https://doi.org/10.15585/mmwr.rr6602a1.CrossRefPubMedPubMedCentral

21.

Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5(5):CD005050. https://doi.org/10.1002/14651858.CD005050.pub3.CrossRef

22.

American Heart Association/American College of Cardiology. Influenza vaccination as secondary prevention for cardiovascular disease. Circulation. 2006;114(14):1549-53.

23.

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S, ESC Scientific Document Group. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81. https://doi.org/10.1093/eurheartj/ehw106.CrossRefPubMedPubMedCentral

24.

2017–2019 Italian National Immunization Plan. Gazzetta Ufficiale della Repubblica Italiana. GU Serie Generale n. 41 del 18 febbraio 2017. www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf. Accessed 19 November 2019.

25.

World Health Organization (WHO). Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461–76.

26.

Bittner V, Sanderson BK. Influenza vaccination in secondary prevention: an opportunity missed. J Cardiopulm Rehabil Prev. 2007;27(4):202–7.CrossRefPubMed

27.

Epicentro. Sistema di sorveglianza Passi. (2019). https://www.epicentro.iss.it/passi/dati/VaccinazioneAntinfluenzale. Accessed 25 September 2019.

28.

Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J. 2004;25(1):25–31.CrossRefPubMed

29.

Gurfinkel EP, de la Fuente RL. Two-year follow-up of the FLU vaccination acute coronary syndromes (FLUVACS) registry. Tex Heart Inst J. 2004;31(1):28–32.PubMedPubMedCentral

30.

Lavallée P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke. 2002;33(2):513–8.CrossRefPubMed

31.

Liu JC, Wang TJ, Sung LC, Kao PF, Yang TY, Hao WR, Chen CC, Hsu YP, Wu SY. Influenza vaccination reduces hemorrhagic stroke risk in patients with atrial fibrillation: a population-based cohort study. Int J Cardiol. 2017;2(32):315–23. https://doi.org/10.1016/j.ijcard.2016.12.074.CrossRef

32.

Modin D, Jørgensen ME, Gislason G, Jensen JS, Køber L, Claggett B, Hegde SM, Solomon SD, Torp-Pedersen C, Biering-Sørensen T. Influenza vaccine in heart failure. Circulation. 2019;139(5):575–86. https://doi.org/10.1161/CIRCULATIONAHA.118.036788.CrossRefPubMed

33.

Verger P, Fressard L, Cortaredona S, Lévy-Bruhl D, Loulergue P, Galtier F, Bocquier A. Trends in seasonal influenza vaccine coverage of target groups in France, 2006/07 to 2015/16: Impact of recommendations and 2009 influenza a(H1N1) pandemic. Euro Surveill. 2018;23(48). https://doi.org/10.2807/1560-7917.ES.2018.23.48.1700801.

34.

Machado A, Kislaya I, Santos AJ, Gaio V, Gil AP, Barreto M, Namorado S, Antunes L, Matias Dias C, Nunes B. Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions. Vaccine. 2018;36(35):5265–72. https://doi.org/10.1016/j.vaccine.2018.07.041.CrossRefPubMed

35.

Nitsch-Osuch A, Gołębiak I, Wyszkowska D, Rosińska R, Kargul L, Szuba B, Tyszko P, Brydak LB. Influenza vaccination coverage among polish patients with chronic diseases. Adv Exp Med Biol. 2017;968:19–34. https://doi.org/10.1007/5584_2016_193.CrossRefPubMed

36.

Astray-Mochales J, López de Andres A, Hernandez-Barrera V, Rodríguez-Rieiro C, Carrasco Garrido P, Esteban-Vasallo MD, Domínguez-Berjón MF, Jimenez-Trujillo I, Jiménez-García R. Influenza vaccination coverages among high risk subjects and health care workers in Spain. Results of two consecutive National Health Surveys (2011-2014). Vaccine. 2016;34(41):4898–904. https://doi.org/10.1016/j.vaccine.2016.08.065.CrossRefPubMed

37.

Yang TU, Song JY, Noh JY, Cheong HJ, Kim WJ. Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching Hospital in South Korea. Infect Chemother. 2015;47(1):41–8. https://doi.org/10.3947/ic.2015.47.1.41.CrossRefPubMedPubMedCentral

38.

Bare I, Crawford J, Pon K, Farida N, Dehghani P. Frequency and consequences of influenza vaccination in adults with congenital heart disease. Am J Cardiol. 2018;121(4):491–4. https://doi.org/10.1016/j.amjcard.2017.11.008.CrossRefPubMed

39.

Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. https://doi.org/10.1016/S0140-6736(12)60240-2.CrossRefPubMed

40.

Harrison SM, Wei MY, Lamerato LE, Petrie JG, Toth ME. Multimorbidity is associated with uptake of influenza vaccination. Vaccine. 2018;36(25):3635–40. https://doi.org/10.1016/j.vaccine.2018.05.021.CrossRefPubMedPubMedCentral

41.

Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26(5):546–50. https://doi.org/10.1007/s11606-010-1609-1.CrossRefPubMedPubMedCentral

42.

Jiménez-García R, Herńndez-Barrera V, Rodríguez-Rieiro C, de Andrés AL, Jd M-D, Trujillo IJ, Carrasco-Garrido P. Are age-based strategies effective in increasing influenza vaccination coverage?: the Spanish experience. Hum Vaccin Immunother. 2012;8(2):228–33. https://doi.org/10.4161/hv.18433.CrossRefPubMed

43.

Bonanni P, Gasparini R, Greco D, Mennini FS, Rossi A, Signorelli C. Abbassamento dell’età di raccomandazione della vaccinazione anti-influenzale a 60 anni: una scelta per la salute e per l’economia del Paese. 2013. http://www.societaitalianaigiene.org/site/new/images/docs/documenti/2013/parereinfluenza.pdf. Accessed 26 Nov 2019.

44.

Frobert O, Götberg M, Jonasson L,Erlinge D, Engstrøm T, Persson J, Jensen SE, Omerovic E, James SK, Lagerqvist B, Nilsson J, , Kåregren A, Moer R, Yang C, Agus DB, Erglis A, Jensen LO, Jakobsen L, Christiansen EH, Pernow J. Design and rationale for the influenza vaccination after myocardial infarction (IAMI) trial. A registry-based randomized clinical trial. Am Heart J 2017; 189: 94–102. doi: https://doi.org/10.1016/j.ahj.2017.04.003.CrossRefPubMed

45.

Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–8.CrossRefPubMed

46.

Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J. 2008;29:96–103.CrossRefPubMed

47.

Warren-Gash C, Geretti AM, Hamilton G, Rakhit RD, Smeeth L, Hayward AC. Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza a H1N1 pandemic in London: a case-control study. BMJ Open. 2013;3(5):e002604.CrossRefPubMedPubMedCentral

48.

Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378:345–53. https://doi.org/10.1056/NEJMoa1702090.CrossRefPubMed

49.

Dalager-Pedersen M, Søgaard M, Schønheyder HC, Nielsen H, Thomsen RW. Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation. 2014;129:1387–96.CrossRefPubMed

50.

Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med. 2019;380(2):171–6. https://doi.org/10.1056/NEJMra1808137.CrossRefPubMed

51.

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.1286.

52.

Li B, Yang J,,Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; https://doi.org/https://doi.org/10.1007/s00392-020-01626-9.

53.

Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; https://doi.org/10.1038/s41569-020-0360-5.

Title: Influenza coverage rates in subjects with chronic heart diseases: results obtained in four consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy)”
Authors: Armando Stefanati
Silvia Lupi
Gianluca Campo
Silvia Cocchio
Patrizia Furlan
Vincenzo Baldo
Giovanni Gabutti
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Influenza Vaccination
Vaccination
Influenza
Published in: Archives of Public Health / Issue 1/2020
Electronic ISSN: 2049-3258
DOI: https://doi.org/10.1186/s13690-020-00487-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Influenza coverage rates in subjects with chronic heart diseases: results obtained in four consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy)”

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Environmental exposures and health behavior in association with mental health: a study design

Correction to: Social determinants of overweight and obesity in the mother-child binomial: evidences from Mexico

Revisiting sequential attributable fractions

How do world and European standard populations impact burden of disease studies? A case study of disability-adjusted life years (DALYs) in Scotland

Age at the onset of tobacco smoking in South Africa: a discrete-time survival analysis of the prognostic factors

Learning from previous work and finding synergies in the domains of public and environmental health: EU-funded projects BRIDGE Health and HBM4EU